Table 2.
The percentage of cytomegalovirus disease and its risk factors in studied kidney transplant recipients of North of Iran
| Variables |
CMV disease
|
P value | |
|---|---|---|---|
|
Positive
N(%) |
Negative
N(%) |
||
| Age group(year) | |||
| 0-20 21-40 41-60 61-80 |
(12.7)10 (19.6)56 (29.3)93 (44.2)19 |
(87.3)69 (80.4)230 (70.7)224 (55.8)24 |
0.0001> |
| Gender | |||
| Male Female |
(24.5)108 (24.6)70 |
(75.5)333 (75.4)214 |
0.9 |
| Weight (Kg) | |||
| 0-60 60.1-120 |
(19.9)62 (28.0)116 |
(80.1)249 (72.0)298 |
0.01 |
| Hypertension + _ |
(24.1)127 (25.8)51 |
(75.9)400 (74.2)147 |
0.69 |
| Diabetes + _ |
(27.7)39 (23.8)139 |
(72.3)102 (76.2)445 |
0.38 |
| IHD1 + _ |
(50.0)2 (24.4)176 |
(50.0)2 (75.6)545 |
0.25 |
| CABG2 + _ |
(33.3)1 (24.5)177 |
(66.7)2 (75.5)545 |
0.99 |
| Dialysis type | |||
| No dialysis Hemodialysis Peritoneal dialysis |
(16.1)10 (25.4)163 (22.7)5 |
(83.9)52 (74.6)478 (77.3)17 |
0.25 |
| Immunosuppressive regimens | |||
| Prednisolone + cyclosporine Cyclosporine + MMF3+ prednisolone Thymoglobulin containing regimen |
(20.7)75 (29.8)85 (23.4)18 |
(79.3)288 (70.2)200 (76.6)59 |
0.02 |
| History of transplant rejection + _ |
(7.7)1 (24.9)177 |
(92.3)12 (75.1)535 |
0.24 |
| History of blood transfusion + _ |
(30.6)11 (24.2)167 |
(69.4)25 (75.8)522 |
0.42 |
| Blood type | |||
| A B AB O |
(23.4)44 (28.4)54 (23.0)14 (23.1)66 |
(76.6)144 (71.6)136 (77.0)47 (76.9)220 |
0.55 |
| RH | |||
| + - |
(23.8)159 (32.8)19 |
(76.2)508 (67.2)39 |
0.15 |
| EBV AB | |||
| Not reported Seropositive Seronegative |
- (25.6)172 (23.1)6 |
(100)27 (74.4)500 (76.9)20 |
0.005 |
| CMV AB | |||
| Not reported Seropositive Seronegative |
- (25.4)175 (30.0)3 |
(100)27 (74.6)513 (70.0)7 |
0.28 |
1
. Ischemic heart disease
2
. Coronary artery bypass graft
3
. Mycophenolate-mofetil